CORRECTING and REPLACING -- Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
February 17, 2016 08:47 ET
|
Alcobra Ltd.
Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline...
Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
February 17, 2016 08:00 ET
|
Alcobra Ltd.
Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Host Corporate Update Conference Call & Webcast on February 17
February 02, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences
January 28, 2016 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Added to the NASDAQ Biotechnology Index
December 17, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Participate in Piper Jaffray 27th Annual Healthcare Conference
November 24, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Present at Upcoming Investment Conferences Company Will Host Corporate Update Conference Call & Webcast on November 17
November 16, 2015 08:00 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. Prices Public Offering of Ordinary Shares
November 13, 2015 08:45 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,175,000 ordinary shares at an...
Alcobra Ltd. Announces Proposed Public Offering of Ordinary Shares
November 12, 2015 16:05 ET
|
Alcobra Ltd.
TEL AVIV, Israel, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. Jefferies LLC and...
Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update
November 12, 2015 16:01 ET
|
Alcobra Ltd.
Conference Call & Webcast November 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time
The company provides an update on its Fragile X Syndrome development program
TEL AVIV, Israel,...